LAMC2, in turn, promoted NSCLC cell proliferation, migration, and invasion by activating the PI3K/Akt signaling pathway and inducing epithelial-mesenchymal transition (EMT). The gene discussed is AKT1; the disease is non-small cell lung carcinoma.